NCT01702597

Brief Summary

The aim of this bicentric, biphasic, randomized, controlled study is to compare of the current gold standard functional treatment to functional treatment plus WBV in patients with acute unilateral unstable inversion ankle sprains over a period of 12 months

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2012

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 8, 2012

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

October 8, 2012

Status Verified

October 1, 2012

Enrollment Period

6 months

First QC Date

October 3, 2012

Last Update Submit

October 4, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postural control

    Sway Index measured via the Leonardo Mechanograph GRFP (16 bit, 800 Hz; NOVOTEC Medical GmbH, Germany)

    6 weeks

Secondary Outcomes (1)

  • Subjective instability

    1 year

Study Arms (2)

WBV

EXPERIMENTAL

Patients will receive supervised physical therapy using a whole body vibration device (Galileo® Med M Plus, Novotec, Pforzheim, Germany) twice a week, 30 minutes per session, for 6 weeks.

Device: Whole body vibration (Galileo® Med M Plus, Novotec, Pforzheim, Germany)

Physiotherapy

ACTIVE COMPARATOR

Patient will receive the current gold standard treatment protocol: supervised physical therapy, twice a week, 30 minutes per session, for 6 weeks.

Other: Physiotherapy

Interventions

Patients will train on a WBV platform, following a standardized protocol, aiming at improving strength, endurance and proprioception of both legs.

Also known as: WBV, Galileo
WBV

Patients will receive a standardized physical therapy.

Also known as: Physical Therapy, Training
Physiotherapy

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Acute, unilateral, unstable, inversion ankle sprain (Grade II, III)

You may not qualify if:

  • Pregnancy
  • Conditions affecting the neuromuscular- or musculoskeletal System
  • Previous surgical interventions to the foot, ankle, knee or hip; known FAI, CAI
  • Conditions possibly affecting balance
  • Cardiovascular disease including thrombosis
  • Respiratory diseases
  • Abdominal diseases (including gallstones)
  • Urological diseases (including kidney- and bladder stones)
  • Gynaecological diseases and + intrauterine devices
  • Neurological diseases including epilepsia within the last 2 years
  • Acute injuries to the head
  • Patient is not available for follow up visits
  • Patient unable to give informed consent
  • Patient suspected to be non-compliant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Baumbach SF, Fasser M, Polzer H, Sieb M, Regauer M, Mutschler W, Schieker M, Blauth M. Study protocol: the effect of whole body vibration on acute unilateral unstable lateral ankle sprain- a biphasic randomized controlled trial. BMC Musculoskelet Disord. 2013 Jan 14;14:22. doi: 10.1186/1471-2474-14-22.

MeSH Terms

Interventions

Physical Therapy Modalities

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Matthias Schieker, Prof.

    Ludwig-Maximilians - University of Munich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 3, 2012

First Posted

October 8, 2012

Study Start

October 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2014

Last Updated

October 8, 2012

Record last verified: 2012-10